Home / Ustekinumab / Spain
ES ATC L04AC05 · updated 2 Nov 2026
Ustekinumab shortage in Spain
Is there a Ustekinumab shortage in Spain?
Yes. As of 2 Nov 2026, 2 Ustekinumab products are reported short in Spain, the first since 2 Jun 2026. The company estimate for the return is 10 Jan 2027 (latest 30 Dec 2027). Main reason: not stated.
Also short in Italy, Ireland, Belgium. All countries.
Affected products in Spain
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| ES | IMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 ml | Accord Healthcare S.L.U. | 2 Jun 2026 | 30 Dec 2027 | Not stated |
| ES | STEQEYMA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | Celltrion Healthcare Hungary Kft. | 7 Oct 2026 | 10 Jan 2027 | Not stated |
Source
AEMPS (Spanish Agency of Medicines and Medical Devices), CIMA. Official list. All authorised presentations with a declared supply problem.